Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-19-051908

Chief Financial Officer bought 2,180 shares at $24.80 ($54,064)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Pizzie Nick Chief Financial Officer 2019-09-26 Purchase +2,180 $24.80 $54,064 40,440 D
Open-market purchases · 2,180 sh · avg $24.80 · $54,064
Loading xslF345X03/a4.xml…